Come up with a name for your new list and we'll add to it:
Traverse Biosciences raised a round of funding on June 06, 2014. Investors include
Accelerate Long Island.
Traverse Biosciences is commercializing an edible prescription medication for the prevention and control of canine periodontal disease, which affects approximately 80% of dogs over the age of two.…